Mukka Proteins Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2025
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins has filed the notice for its 15th Annual General Meeting scheduled for September 18, 2025 at 3:00 PM via video conferencing, along with the annual report for FY 2024-25. The company reported a 30.10% decline in standalone revenue to ₹8,867.43 million and a fall in standalone profit after tax to ₹416.83 million (from ₹627.56 million). On a consolidated basis, revenue dropped 27.06% to ₹10,064.16 million, with profit after tax at ₹480.97 million (from ₹743.05 million). The board has not recommended any dividend for FY 2024-25, citing the need to strengthen finances and augment working capital. Remote e-voting runs from September 15-17, 2025, with a cut-off date of September 11, 2025 for voting eligibility. During the year, Ento Proteins became a subsidiary (stake raised from 50% to 74%) and a proposed preferential issue of 1.96 crore shares was withdrawn by the proposed allottees.
The year-on-year revenue and profit decline along with a skipped dividend may weigh negatively on the stock in the short term, though the AGM itself is a routine procedural event. The withdrawn preferential issue removes near-term dilution risk, and the e-voting window allows shareholders to participate in decisions including the re-appointment of two directors.